A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic-pathway regulation and receptor-binding kinetics in preclinical research models. For research use only — not for human or veterinary use.
The compounds in this catalog are referenced in published scientific literature across the following research areas. All references for educational purposes only.
In vitro receptor affinity, kinetics, signal transduction.
HPLC reference, mass spec calibration, purity verification.
Assay protocol design, validation, optimization.
